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Bone morphogenetic proteins (BMP) are members of
the transforming growth factor-b superfamily regulat-
ing a large variety of biologic responses in many di¡er-
ent cells and tissues during embryonic development and
postnatal life. BMP exert their biologic e¡ects via bind-
ing to two types of serine/threonine kinase BMP recep-
tors, activation of which leads to phosphorylation and
translocation into the nucleus of intracellular signaling
molecules, including Smad1, Smad5, and Smad8 (‘‘ca-
nonical’’ BMP signaling pathway). BMP e¡ects are also
mediated by activation of the mitogen-activated
protein (MAP) kinase pathway (‘‘noncanonical’’ BMP
Signaling pathway). BMP activity is regulated by di¡u-
sible BMP antagonists that prevent BMP interactions
with BMP receptors thus modulating BMP e¡ects in
tissues. During skin development, BMPs its receptors
and antagonists show stringent spatiotemporal expres-
sions patterns to achieve proper regulation of cell prolif-
eration and di¡erentiation in the epidermis and in the
hair follicle. In normal postnatal skin, BMP are in-
volved in the control of epidermal homeostasis, hair
follicle growth, and melanogenesis. Furthermore, BMP
are implicated in a variety of pathobiologic processes in
skin, including wound healing, psoriasis, and carcino-
genesis. Therefore, BMPs represent new important
players in the molecular network regulating homeosta-
sis in normal and diseased skin. Pharmacologic modu-
lation of BMP signaling may be used as a new approach
for managing skin and hair disorders. Key words:
BMP/Noggin/proliferation/di¡erentiation/apoptosis J Invest
Dermatol 120:36 ^47, 2003
B
one morphogenetic proteins (BMP) are the largest
family of secreted signaling molecules of the trans-
forming growth factor (TGF)-b superfamily. BMP
have been ¢rst isolated from bone extracts and dis-
played ability to induce ectopic bone formation and
to heal bone defects in experimental animals (Wozney et al, 1988;
Reddi, 1998). It was later shown, however, that BMP function as
multifunctional regulators of vertebrate development controlling
cell proliferation, di¡erentiation, and apoptosis in di¡erent body
tissues, including skin (reviewed in Hogan, 1996a, b; Massaque
and Chen, 2000). Furthermore, increased evidence suggests that
during postnatal life, BMP play important parts in normal tissue
homeostasis and are also implicated in a variety of pathobiologic
processes (reviewed in Myazono et al, 2001).
Currently, the BMP family consists of more than 20 secreted
proteins that share structural homology exerting their biologic ac-
tivity via interaction with speci¢c BMP receptors (Massague, 1998;
Itoh et al, 2000; Myazono et al, 2001). While showing a
certain structural similarity to other members of TGF-b super-
family, BMP ful¢ll a large number of distinct speci¢c functions
in animals and humans as shown by genetic and experimental stu-
dies. In this review, we summarize data on the roles for BMP in
the biology of normal and diseased skin. Speci¢cally, we show that
BMP function not only as powerful regulators of cutaneous devel-
opment, but also play important role: in the control of epidermal
homeostasis, hair follicle growth, and melanogenesis in normal
postnatal skin. Furthermore, we show that BMP are involved in
the control of a variety of pathobiologic processes in postnatal
skin, including wound healing, psoriasis, and carcinogenesis.
STRUCTURE OF BMPAND THEIR RECEPTORS
BMP are synthesized as precursor molecules, which are clea-
ved by subtilisin-like proteases to release a carboxy-terminal
A publication of the
Progress in  
Dermatology
Reprint requests to: Vladimir A. Botchkarev, Department of Dermatol-
ogy, Boston University School of Medicine, 609 Albany Street, Boston,
MA 02118, U.S.A. E-mail: VLadbotc@bu.edu
nThis review is dedicated to the 80th Anniversary of the corresponding
member of Russian Academy of Natural Sciences Prof Dr Dina S. Gordan,
whose support and wisdom helped the author enormously in his career.
The production of this issue of Progress in Dermatology has been subsi-
dized by Galderma Laboratories, LLP
Abbreviations: BMP, bone morphogenetic protein; BMPR, bone mor-
phogenetic protein receptor; Shh, Sonic Hedgehog.
Manuscript received August 19, 2002; accepted for publication August
21, 2002
0022-202X/03/$15.00  Copyrightr 2002 by Dermatology Foundation, 1560 Sherman Avenue, Evanstan, Illinois 60201
36
monomer (Constam and Robertson, 1999). Each BMP monomer
consists of approximately 100^140 amino acids (Celeste et al, 1990;
Reddi, 1998). Two disul¢de-linked monomers form biologically
active homo- or heterodimers, which are subsequently released
to the extracellular matrix to interact with BMP receptors
(BMPR). In mammals, BMP structure is highly conserved and
comparison of mature regions of human and mouse BMP reveals
in most cases 90^100% homology (Reddi, 1998). Based on amino
acid sequence homology, the BMP superfamily is divided into
several subgroups (Table I), all of which share a motif containing
six cysteine residues and forming a rigid structure (cysteine knot)
at the base of every mature monomer (Reddi, 1998).
BMP bind and activate cell signal transduction through a
transmembrane receptor complex formed by type I and type II
receptors (reviewed in Massaque and Chen, 2000; Myazono et al,
2001; Fig 1). Individual type I (BMPR-IA and BMPR-IB) and
type II (BMPR-II) receptors have a low a⁄nity for BMP, while
the heterotetrameric complex of type I and type II receptors show
high-a⁄nity binding to BMP dimers. Both types of receptors
contain intracellular serine/threonine kinase domains, and the
type II receptor kinases are constitutively active without BMP
stimulation. However, type II receptors are not capable of initiat-
ing signaling independently. Ligand binding to the heterotetra-
meric complex of type I and type II receptors results in
phosphorylation of the intracellular domain of type I receptor
by type II receptor kinases and leads to the transmission of the
intracellular signal through ‘‘canonical’’ and ‘‘noncanonical’’ BMP
pathways.
BMPR-IA (or activin-like kinase-3, ALK-3) and BMPR-IB
(or ALK-6) are both 64 kDa transmembrane glycoproteins that
show 98% and 96% homology in humans and mice, respectively
(ten Dijke et al, 1994a,b). Human BMPRII is an 80 kDa glycopro-
tein with 97% homology to murine BMPRII (Beppu et al, 1997).
In most cases, BMPR-IA and BMPR-IB form a heterotetrameric
complex with BMPRII. There is a possibility, however, for other
receptors of TGF-b superfamily (activin receptor type I or ALK-
2, activin receptor type II,TGF-b receptor type II) to be a part of
the BMPR complex and bind certain BMP (BMP2, BMP6,
BMP7) (Itoh et al, 2000; Myazono et al, 2001). Speci¢city in bind-
ing BMPR complex appears to be determined by the type I re-
ceptor, while type II receptor is more important for the activation
of signal transducing mechanisms (Liu et al, 1995; Massague, 1998).
BMP signaling may be blocked by the pseudo-receptor BAMBI
(BMP and activin membrane bound inhibitor), a transmembrane
protein with extracellular domain similar to that of type I BMP
receptors (Onichtchouk et al, 1999).
Similar to many other growth factor families, BMP signaling
is regulated on several levels: (i) at the cell surface, by modulating
BMP binding to the BMPR complex; (ii) at the cytoplasm, by
activating or inhibiting BMP signal transduction pathways; (iii)
Table I. Structure of the selected members in the bone morphogenetic protein familya,b
BMP subfamily Designation (generic name) Structure % identity (human/mouse)
BMP2/4 BMP-2 (BMP-2A) 114 aa 100
BMP-4 (BMP-2B) 116 aa 98
BMP-3 BMP-3 (Osteogenin) 110 aa 98
BMP-3B (GDF-10) 110 aa 99
BMP-7/OP-1 BMP-5 138 aa 96
BMP-6 (Vegetal related-1) 139 aa 96
BMP-7 (Osteogenic protein-1) 139 aa 98
BMP-8 (Osteogenic protein-2) 139 aa 94
BMP-8B (Osteogenic protein-3) 139 aa 100
BMP-9/ BMP-10 BMP-9 (GDF-2) 110 aa 95
BMP-10 108 aa 100
BMP-11/GDF-8 BMP-11 (GDF-11) 109 aa 100
GDF-8 109 aa 100
BMP-12/BMP-13/BMP-14 BMP-12 (GDF-7) 104 aa 98
BMP-13 (GDF-6) 120 aa 99
BMP-14 (GDF-5) 120 aa 98
BMP-15 BMP-15 125 aa 71
aTable summarizes data on the molecular structure of BMP family members obtained from the original publications and reviews (Wozney et al, 1988; Feng et al, 1994;
Hogan, 1996b; Reddi, 1998; Gamer et al, 1999; Otsuka et al, 2001).
bBMP-1 is not a member of BMP superfamily and is a cysteine-rich peptidase, which cleaves BMP antagonist chordin (Piccolo et al, 1997).
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Figure1. Schematic representation of the ‘‘canonical’’ BMP^Smad
pathway and ‘‘noncanonical’’ BMP^MAPK pathway (modi¢ed
from von Bubno¡ and Cho, 2001). BMP interactions with BMPR
complex is regulated by di¡usible BMP antagonists that prevent BMP
binding to BMP receptors. Binding of the free BMP to BMP receptor
complex activate either BMP^Smad or BMP^MAPK signal transduction
pathways. The BMP^Smad pathway includes recruitment and phosphory-
lation of R-Smad followed by the formation of their complexes with Co-
Smad and translocation into the nucleus to regulate gene transcription.
BMP^MAPK pathway via recruitment of XIAP and TAB1 links BMP re-
ceptors withTAK1kinase, which in turn may activate apoptosis via p38/Jnk
pathway.
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in the nucleus, by controlling transcription of BMP target genes.
Below, we summarize molecular mechanisms that underlie each
level of regulation of BMP signaling in cells.
MODULATION OF BMPACTIVITY BY SECRETED BMP
ANTAGONISTS
The activity of BMP at the cell surface is modulated by a number
of secreted BMP antagonists that prevent BMP binding to BMP
receptors. BMP antagonists (noggin, chordin, follistatin, cer-
berus/DAN family of proteins) belong to structurally distinct
protein families (reviewed in Massaque and Chen, 2000). All of
these proteins, however, bind members of the BMP family with
a⁄nity higher than the BMPR complex, thus restricting BMP
activity to the tissue compartments that are free of BMP antago-
nists (Fig 2). Also, some BMP antagonists are able to bind simul-
taneously BMP and other growth factors and institute a balance
of growth regulators in the tissue (Perrimon and McMahon,
1999).
Noggin is 222 amino acid protein that binds BMP-2 and
BMP-4 with a⁄nity 10^15 times higher than BMP receptors
and neutralizes the activity of BMP-2 and BMP-4 (Zimmerman
et al, 1996). Noggin also binds with lower a⁄nity to BMP-7. It
was recently shown that noggin, remaining active as BMP-
neutralizing protein, has a strong a⁄nity to heparan sulfate
proteoglycans, which are abundantly expressed on the surface of
all adherent cells and in the extracellular matrix (Paine-Saunders
et al, 2002). Thus, heparan sulfate proteoglycans may regulate the
tissue distribution of the BMP antagonist noggin and restrict cel-
lular responsiveness to BMP. Interestingly, BMP are capable of
inducing noggin expression and initiating a negative feedback
loop limiting their own activity (Gazzerro et al, 1998).
Chordin is a 120 kDa protein, which binds to BMP2 and
BMP4 with a⁄nity approximately 10 times lower, than noggin
(Piccolo et al, 1996; Zimmerman et al, 1996). The recently discov-
ered chordin-like protein also interacts with BMP and, in addi-
tion, display a weak binding to TGF-b (Nakayama et al, 2001).
Chordin in the complex with BMP may be cleaved by BMP-1
metalloproteinase with subsequent release of biologically active
BMP (Piccolo et al, 1997). BMP-1 metalloproteinase, however,
cannot degrade noggin (Wardle et al, 1999). This suggests that
regulation of BMP interactions with BMP receptors is a
complex mechanism, including not only neutralization of the ex-
tracellular pool of BMP by secreted BMP antagonists, but also
a degradation of selected BMP antagonists by extracellular
metalloproteinase.
Follistatin is 35 kDa protein that binds activin, a member of
TGF-b superfamily, with high a⁄nity preventing its interaction
with activin receptors (Patel, 1998). Activin exerts a large number
of biologic responses, which are distinct from BMP e¡ects on tis-
sues (reviewed in Munz et al, 2001). Follistatin can bind BMP-2,
BMP-4, BMP-7, and BMP-15 with low a⁄nity and subsequently
modulate their interactions with the BMPR complex (Fainsod et
al, 1997; Patel, 1998; Otsuka et al, 2001). It has recently been shown
that a novel follistatin-like protein can simultaneously bind acti-
vin and BMP-2 (Tsuchida et al, 2000). Thus, both follistatin and
follistatin-like protein, whereas inhibiting interactions of activin
and BMP with their corresponding receptors, may coordinate
their e¡ects in tissues.
The DAN/cerberus family of proteins includes DAN, gremlin,
cerberus, and Caronte, all of which contain a cystein-rich region
responsible for binding to BMP (Massaque and Chen, 2000).
Proteins of this family can neutralize not only BMP activity, but
also several other growth factors. Cerberus functions as a multi-
valent growth factor antagonist that interacts in the extracellular
space with BMP,Wnt proteins, and the TGF-b family member
Nodal via distinct sites in its molecule (Piccolo et al, 1999). This
suggests that distinct combinations of locally secreted BMP an-
tagonists may establish a balance or gradient of growth factors
and optimize their local concentrations su⁄cient for induction
or suppression of certain biologic e¡ects in di¡erent tissue com-
partments (Fig 2).
INTRACELLULAR BMP SIGNALING CASCADE
Increased evidence suggests that BMP after binding to BMP re-
ceptor complex activate at least two signal transduction pathways:
‘‘canonical’’ signaling pathway that includes the Smad family
of proteins and ‘‘noncanonical’’ BMP^mitogen-activated protein
kinase (BMP^MAPK) pathway (Fig 1). The ‘‘canonical’’ BMP^
Smad signaling pathway has been intensively characterized dur-
ing the last decade (reviewed in Heldin et al, 1997; Massague,
1998; Itoh et al, 2000; Myazono et al, 2001). In the last few years,
it has been shown that many e¡ects of BMP are also mediated by
the BMP^MAPK pathway that appears to operate independently
of the BMP^Smad pathway (reviewed in von Bubno¡ and Cho,
2001). Recent data suggest that the distinct activation of these two
pathways depends on the mode of ligand binding to BMP recep-
tors. Binding to preformed receptor complexes induces signal
transduction via the BMP^Smad pathway, whereas binding to
the BMPR-I with subsequent recruitment of BMPR-II activates
the BMP^MAPK pathway (Nohe et al, 2002). Below, we review
the mechanisms that are involved in BMP signal transduction
through the BMP^Smad and BMP^MAPK pathways.
BMP^Smad (‘‘canonical’’) pathway Following BMP
binding to the heteromeric BMPR complex, BMPRII
phosphorylates the glycine/serine-rich domain of the type I
receptors, which in turn phosphorylates speci¢c Smad proteins
(Fig 1). In mammals, the Smad family consists of eight proteins
structurally related to the Drosophila Mad (Mother against
decapentaplegic) protein (reviewed in Raftery and Sutherland,
1999). Smad1, Smad5, and Smad8 (or receptor-activated Smad,
R-Smad) are each phosphorylated by BMPR-I kinases and then
form heteromeric complexes with Smad4 (or common-partner
Smad, Co-Smad). R-Smad/C-Smad complex subsequently
translocates to the nucleus to regulate transcription of BMP
responsive genes (Fig 2). Smad2 and Smad3, which also belong
to the R-Smad subfamily, are activated by ActRI and TGF-bRI
kinases and do not appear to be mediators of the BMP signaling
pathway (Moustakas et al, 2001).
Smad6 and Smad7 (or inhibitory Smad, I-Smad) antagonize
the phosphorylation of Smad1, Smad5, and Smad8 by BMPR-I
kinases. Also, Smad6 might inhibit BMP signaling by
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Figure 2. Scheme illustrating the regulation of BMP activity in tis-
sue by the gradient of secreted BMP antagonists. BMP antagonists
(noggin, chordin, follistatin, cerberus/DAN family of proteins) bind mem-
bers of the BMP family with a⁄nity higher than the BMPR complex,
thus preventing BMP interaction with BMP receptors (as indicated at the
peripheral part of the scheme). Thus, BMP activity is restricted to the tissue
compartments that are free of BMP antagonists (as indicated at the central
part of the scheme).
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competing with Smad4 for binding to Smad1 (Hata et al, 1996).
Interestingly, Smad1/Smad5 and Smad3 can induce the
expression of Smad6 and Smad7, respectively, suggesting a
negative feedback loop in ‘‘canonical’’ BMP signaling pathway
(Nagarajan et al, 1999; Ishida et al, 2000). Antagonistic e¡ects of
Smad6 in the BMP^Smad pathway may be blocked by the
intracellular adaptor protein AMSH, which directly binds
Smad6 and interferes with the interactions between Smad 6 and
R-Smad (Itoh et al, 2001). Basal levels of R-Smad and their
availability for BMP signaling is regulated by Smurf1 (Smad
ubiquitination regulatory factor-1), a protein that interacts with
Smad1 and Smad5 independently of their phosphorylation status
to promote their degradation in proteosomes (Zhu et al, 1999).
Both R-Smad and Smad4 display domains with similar amino
acid sequences at the N- and C-terminal, called MH1 and MH2,
respectively. After translocating into the nucleus, the complex of
Smad4 and one of the R-Smad (Smad1 or Smad5) binds DNA
through MH1 domains that contain speci¢c DNA-binding
sequences (GCCG for Smad1 and TGTGC for Smad5)
(Kusanagi et al, 2000; Li et al, 2001). Transcription of BMP target
genes is regulated positively or negatively depending on which
coactivator(s) or corepressor(s) interact with MH2 or MH1
domains of the R-Smad/Smad4 complex.
During the last few years, many transcriptional regulators that
bind Smad in the nucleus have been identi¢ed (reviewed in Itoh
et al, 2000; Myazono et al, 2001; ten Dijke et al, 2002). The general
transcription coactivator p300, OAZ zinc ¢nger transcription
factor, and SMIF (Smad4-interacting protein) activate BMP-
mediated transcription (Nakashima et al, 1999; Pearson et al, 1999;
Hata et al, 2000; Bai et al, 2002). Ski protein directly interacts with
the MH2 domain of Smad1 and Smad5 and operates as
transcriptional repressor of BMP^Smad signaling (Wang et al,
2000b). Also, other cofactors, Smad nuclear interacting protein-
1 or SNIP1 and anti-proliferative protein Tob, both may
negatively regulate BMP^Smad transcription (Kim et al, 2000;
Yoshida et al, 2000).
BMP^MAPK (‘‘noncanonical’’) pathway It has recently
been shown that the activated BMPR complex may interact
with intracellular adaptor protein XIAP, which links BMP
receptors with TAB1 (TAK1 binding protein) that, in turn,
activates TAK1 (TGF-b activated kinase 1) (Yamaguchi et al,
1999). TAK1 is a member of MAPK kinase kinase family, whose
activity is stimulated by TGF-b1 and BMP4 (Fig 1).
Subsequently, TAK1 activates a distantly related MAP kinase
family member Nemo-like kinase (NLK), which has been
shown to inhibit phosphorylation of TCF-1/Lef-1 transcription
factors and downregulate Wnt/b-catenin-dependent trans-
cription (Ishitani et al, 1999). Also, it was shown that TAK1
activates p38 and JNK pathways, which are involved in BMP-
induced apoptosis (Kimura et al, 2000; Zhang et al, 2000).
Interestingly, Smad6 has been shown to bind and inhibit TAK1
activity (Kimura et al, 2000), suggesting links between BMP^
Smad and BMP^MAPK pathways.
BMP ROLES DURING DEVELOPMENT
Morphologic and genetic studies have demonstrated the essential
roles for BMP in embryonic development. BMP, BMP receptors,
and R-Smad are broadly expressed in a large variety of develop-
ing tissues and organs (Lyons et al, 1989, 1990; Bitgood and
McMahon, 1995;Takahashi and Ikeda, 1996; Dick et al, 1998; Flan-
ders et al, 2001). Loss-of-function mutations of BMP-2, BMP-4,
BMPR-IA, Smad1, Smad4, and Smad5 lead to early embryonic leth-
ality due to multiple defects in developing mesoderm, ectoder-
mal, and endodermal derivatives (Table II; reviewed in (Hogan,
1996a, b;Whitman, 1998; Itoh et al, 2000). Constitutive deletion of
BMP antagonist noggin or double mutation of noggin and chordin
also result in lethality in later stages of embryonic development,
in part because of abnormalities in brain and skeletal develop-
ment (Brunet et al, 1998; McMahon et al, 1998; Bachiller et al,
2000). Genetic ablation of Smad6, one of the inhibitory Smad,
leads to defects in cardiac valve formation and other cardiovascu-
lar abnormalities (Galvin et al, 2000). This suggests that BMP
activity during embryonic development is tightly regulated,
and both loss and gain of BMP functions result in severe devel-
opmental defects.
During embryonic development, BMP regulate multiple cell
functions, including proliferation, di¡erentiation, apoptosis,
adhesion properties, and migration (reviewed in (Hogan, 1996a,
b;Whitman, 1998). As was shown in many developmental struc-
tures, BMP activity in the extracellular space is limited by a gra-
dient of locally secreted BMP antagonist(s) preventing BMP
binding to BMP receptors (Fig 2). The cellular response to
BMP is also dependent on a variety of other factors, including
which BMP binds the receptor, the type of receptor (BMPR-IA
or BMPR-IB) that is activated by the ligand, the di¡erentiation
state of the cell, activity of other growth stimulatory or inhibi-
tory factors, stage of embryogenesis, etc. Below, we brie£y
summarize the e¡ects of BMP and their antagonists on cell pro-
liferation, di¡erentiation, and apoptosis during development.
BMP and cell proliferation Numerous data suggest that BMP
may stimulate or inhibit cell replication during development
depending on cell types and circumstances. As it was shown in
many models (neural precursor cells, brain cells, osteogenic and
chondrogenic progenitors), BMP stimulate proliferation via
Table II. Phenotypes of mice with constitutive deletion of genes encoding BMP, BMP receptors, Smad, or BMP antagonists
Gene targeted Phenotype Reference
BMP2 Embryonic lethality (E9.5) due to defects in amnion and heart development (Zhang and Bradley, 1994)
BMP4 Early embryonic lethality due to the defect in gastrulation and mesoderm formation (Winnier et al, 1995)
BMP7 Die shortly after birth from renal failure, also show defects in eye development (microphthalmia) (Dudley et al, 1995; Luo et al, 1995)
and polydactyly
BMPR-IA Early embryonic lethality due to the defect in gastrulation and mesoderm formation (Mishina et al, 1995)
BMPR-IB Viable, multiple skeletal defects, and female infertility (Yi et al, 2000;Yi et al, 2001)
Smad1 Embryonic lethality (E9.5^10.5) due to defects in extra-embryonic tissues (allantois, placenta) (Lechleider et al, 2001; Tremblay et al, 2001)
Smad4 Embryonic lethality (E7.5^8.5) due to defects in mesoderm formation, gastrulation, (Sirad et al, 1998;Yang et al, 1998)
and extra-embryonic tissues
Smad5 Die between E9.5 and E11.5, show numerous defects in developing amnion, gut, (Chang et al, 1999;
heart, and nervous system Yang et al, 1999)
Smad6 Viable, defects in cardiovascular system (formation of cardiac valves, elevated blood pressure) (Galvin et al, 2000)
Noggin Die at E18.5 due to abnormalities in nervous system and skeletal development (Brunet et al, 1998; McMahon et al, 1998)
Noggin/Chordin Embryonic lethality due to the defects in forebrain development (Bachiller et al, 2000)
1Yaar M, Park H-Y, BotchkarevVA, Stewart K, Panova I, Gilchrest BA: Bone morphogenetic protein 4 modulates melanocyte proliferation and melanogenesis. J Invest
Dermatol 119:337, 2002, in press (Abstr.)
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activation of BMPR-IA signaling (Arkel and Beddington, 1997;
Yamaguchi et al, 2000; Panchison et al, 2001). Indeed, BMPR-IA
knockout mice show reduced cell number in epiblast by 20^
30%, compared with wild-type mice (Mishina et al, 1995). In
developing kidney, low doses of BMP7 increase proliferation
of tubule cells, whereas high doses inhibit cell proliferation
and stimulate apoptosis (Piscione et al, 2001). This suggests that
BMP e¡ects on cell proliferation strongly depend on ligand
concentration in the close vicinity of the target cell.
Interestingly, as was shown in neural cell progenitors, BMPR-
IA activation, promoting cell proliferation, simultaneously
induces BMPR-IB expression (Panchison et al, 2001). Subse-
quently, BMPR-IB activation causes mitotic arrest and di¡er-
entiation or apoptosis in neural progenitor cells (Panchison et al,
2001). This mechanism may explain how the sequential actions of
BMP receptors control the production and fate of cells during
development. It remains to be determined, however, which
intracellular signaling pathways are recruited for induction of
proproliferative and/or anti-proliferative e¡ects of BMP during
BMPR-IA and BMPR-IB activation.
BMP and cell di¡erentiation Numerous data suggest that
BMP play important parts in initiating and promoting cell
di¡erentiation during development. In developing embryo,
BMP promote di¡erentiation of a large variety of distinct cell
types, including neural progenitors, cardiomyocytes, osteoblasts
and chondroblasts, adipocytes, renal tubule cells, hematopoietic
cells, etc. In every distinct cell type, BMP induce expression of
the lineage-speci¢c transcription factors or markers, such as
Cbfa1 and alkaline phosphatase in osteoblasts (Yamaguchi et al,
2000), ATF-2 in cardiomyocytes (Monzen et al, 2001), or adipsin
and peroxisome proliferator activated receptor-g in adipocytes
(Chen et al, 1998).
Recent studies provide evidence that BMP-induced cell
di¡erentiation is mediated by both BMPR-IA and BMPR-IB,
requires the recruitment of ‘‘canonical’’ and ‘‘noncanonical’’ BMP
signaling pathways and is regulated di¡erently in di¡erent
cell types. Both BMPR-IA and BMPR-IB are implicated
in chondrocyte di¡erentiation (Zou et al, 1997; Yi et al, 2000).
The beginning of neuronal progenitor di¡erentiation in
mouse embryo is accompanied by the onset of BMPR-IB
expression (Panchison et al, 2001). In mesenchymal cell pro-
genitors, activation of BMPR-IA signaling induces adipocyte
di¡erentiation, whereas stimulation of BMPR-IB promotes
expression of markers speci¢c for osteogenic lineage (Chen et al,
1998). In di¡erentiating cardiomyocytes, BMP induce ATF-2
transcription factor via recruitment of Smad1 and TAK1,
suggesting that both ‘‘canonical’’ and ‘‘noncanonical’’ pathways
cooperate in the initiation of a cardiomyocyte di¡erentiation
program in progenitor cells (Monzen et al, 2001).
During tooth development, BMP4 induces in cells of enamel
knot the expression of the cyclin-dependent kinase inhibitor p21
(Jernvall et al, 1998), which is critical for cell transition from
proliferation to di¡erentiation (reviewed in Dotto, 2000). Also,
in vitro studies suggest that growth inhibitory e¡ects of BMP are
associated with induction of both p21 and p27, and Smad1
binding sites are recently described on p21 promoter (Franzen
and Heldin, 2001;Yamato et al, 2001).
Interestingly, BMP also plays a part in regulating cell adhesion-
molecule expression during development. In di¡erentiating
osteoblasts, BMP2 stimulates expression of N- and E-cadherins,
whereas expression of the neural cell adhesion molecule remains
unchanged (Hay et al, 2000). In vitro studies on human fetal
chondrocytes suggest that BMP-2 downregulates the expression
of a3b1 integrin thus decreasing the ability of cells to attach to
the substrate (Nissinen et al, 1997). Given that cell di¡erentiation
and/or migration are ultimately accompanied by reorganization
of the cell adhesion apparatus, di¡erential e¡ects of BMP on
the expression of distinct adhesion molecules may represent
an important mechanism modulating processes of cell
di¡erentiation during development.
BMP and apoptotic cell death BMP have been reported to
exert both pro-apoptotic and anti-apoptotic e¡ects during
development. BMP mediate apoptosis in a variety of
developmental structures: neural tube, neural crest progenitors,
mesenchymal cells of interdigital spaces, cells of developing eye,
calvarial bone, and tooth enamel knot (Graham et al, 1996; Zou
and Niswander, 1996; Jernvall et al, 1998; McMahon et al, 1998;
Rice et al, 1999; Trousse et al, 2001). As was shown for other
developmental events associated with the regulation of BMP
activity, local expression of noggin prevents BMP-induced
apoptosis, which only occurs in areas deprived of noggin (Smith
and Graham, 2001).
Several lines of evidence suggest that BMP-mediated apoptosis
is initiated via activation of signaling through BMPR-IB (Zou et
al, 1997; Tang et al, 2000; Panchison et al, 2001). Retinoic acid
serves as an important upstream e¡ector of BMP-induced cell
death (Dupe et al, 1999; Rodriguez-Leon et al, 1999), whereas
Msx-2 and p21 are involved as downstream components in
BMP-mediated apoptosis (Marazzi et al, 1997; Gomes and
Kessler, 2001). It has been recently shown that BMP2 induces
apoptosis in mouse hybridoma cell line MH-60 via a
‘‘noncanonical’’ signal transduction pathway, which requires
activation of TAK1 and p38 kinases (Kimura et al, 2000; Zhang et
al, 2000). Smad6 that directly bind and inhibit TAK1 activity, may
negatively regulate BMP-induced apoptosis (Kimura et al, 2000).
In myeloma cell lines, BMP-2 induces cell cycle arrest followed
by apoptosis associated with upregulation of p21 and hypo-
phosphorylation of the retinoblastoma protein (Kawamura et al,
2000). BMP-mediated apoptosis requires the participation of the
Bcl-2/Bax family of proteins. BMP-2 induces downregulation of
Bcl-xL expression in myeloma cells and Bax participates in BMP-
induced apoptosis in sympathetic neuroblasts (Gomes and Kessler,
2001). Stimulating apoptosis in myeloma cells, BMP-2 and BMP-4
antagonize the growth-promoting activity of interleukin-6 via
downregulation of tyrosine phosphorylation and DNA binding
activity of the STAT3 transcription factor (Kawamura et al, 2000;
Hjertner et al, 2001).
As was shown in several models, however, BMP may also
suppress apoptosis via recruitment of the ‘‘canonical’’ Smad
pathway. Smad5-knockout mice show increased levels of
mesenchymal apoptosis in those areas, where Smad5 is normally
expressed (Yang et al, 1999). In di¡erentiating cardiomyocytes,
BMP-2 inhibits apoptosis induced by serum deprivation (Izumi et
al, 2001). Survival-promoting e¡ects of BMP-2 are mediated by
Smad1, which induces upregulation of the anti-apoptotic protein
Bcl-xL (Izumi et al, 2001). BMP-2 and BMP-4 are also able to
suppress tumor necrosis factor-a-induced apoptosis in C2C12
cells, a pluripotent mesenchymal cell line that shows ability to
di¡erentiate into osteoblasts after BMP stimulation (Chen et al,
2001). Interestingly, anti-apoptotic e¡ects of BMP in this model
are not associated with pro-survival activity of nuclear factor-kB
and are most likely mediated by the Smad pathway (Chen et al,
2001).
BMPAND BMPANTAGONISTS IN CUTANEOUS
DEVELOPMENT
BMP play pivotal roles in the development of skin and cutaneous
appendages. During gastrulation, when ectodermal cells choose
between two fates (neural and epidermal), BMP-4 induces epi-
dermal di¡erentiation and inhibits neural development (Wilson
and Hemmati-Brivanlou, 1995). During later steps of embryonic
development, BMP, BMP antagonists, BMP receptors, and Smad
proteins show stringent spatiotemporal expression patterns in
skin epithelium and mesenchyme, as well as in neural crest cells
that di¡erentiate into melanocytes and components of cutaneous
innervation (neurons, glial cells). Genetic and experimental data
suggest that BMP interact with members of other growth factor
families [Wnt, Sonic Hedgehog (Shh),TGF-b, epidermal growth
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factor, ¢broblast growth factor, Notch] to control cell prolifera-
tion, di¡erentiation, and apoptosis in developing skin and its ap-
pendages. Below, we summarize the data on the expression and
roles for BMP in the development of skin epithelium and skin
appendages.
BMP and epidermal development Members of the BMP
family are di¡erentially expressed in embryonic epidermis.
In situ hybridization and immunohistochemical data suggest that
high levels of both BMP-6 transcripts and BMP-6 protein are
present in suprabasal layers of embryonic murine epidermis
already at E15.5 (Lyons et al, 1989; Wall et al, 1993). Strong
expression of BMP-7 mRNA is seen in the basal epidermal
layer during the last stages of embryonic development
(Takahashi and Ikeda, 1996). This suggests that both BMP-6 and
BMP-7 are involved in the control of cell proliferation and
di¡erentiation in the epidermis. Expression of BMP-2 and
BMP-4 transcripts in developing murine skin are more
restricted to hair follicle epithelium and mesenchyme,
respectively (Lyons et al, 1989, 1990; Bitgood and McMahon,
1995). Expression of the BMP antagonist noggin is seen in
mesenchymal cells under the basal membrane of the epidermis
at E15.5^17.5, whereas later noggin is restricted to the dermal
papilla and connective tissue sheath of the hair follicle
(Botchkarev et al, 1999).
At E16.5, BMPR-IA protein is expressed in the basal layer of
the epidermis, whereas BMPR-IB expression is restricted to
keratinocytes of the suprabasal layer (Botchkarev et al, 1999).
These data are consistent with results obtained from other
developmental models, suggesting that BMPR-IA expression is
largely restricted to proliferating cells, whereas the expression of
BMPR-IB is associated with the onset of cell di¡erentiation
(Panchison et al, 2001). Signal transduction components of
‘‘canonical’’ BMP^Smad pathways Smad1, Smad5, and Smad6
proteins are also abundantly expressed in developing murine
epidermis, suggesting a role for BMP signaling in epidermal
development (Dick et al, 1998; Flanders et al, 2001).
To study the role of BMP-6 in epidermal development,
transgenic mice overexpressing BMP-6 under the control of
keratin (K)10 promoter were generated (Blessing et al, 1996). The
data obtained from BMP-6 overexpressing mice suggest that the
e¡ects of BMP-6 on epidermal development strongly depend on
the levels of transgene expression. High expression of BMP-6
transgene in suprabasal epidermal layer inhibits epidermal
proliferation and does not markedly change the distribution of
di¡erentiation markers (Blessing et al, 1996). Our data obtained
from embryonic murine skin explants cultured with high
concentrations of BMP4 also suggest that strong stimulation of
BMP receptor signaling inhibits epidermal proliferation
(Botchkarev et al, 1999). Moderate BMP-6 expression in BMP-6
transgenic mice, however, stimulates proliferation of basal
epidermal keratinocytes, leads to aberrant appearance of
proliferating cells and K14 expression in suprabasal epidermis,
and also results in partial replacement of the normal K1 and K10
expression in suprabasal epidermal keratinocytes by K6 and K16
(Blessing et al, 1996).
Our data obtained from the noggin knockout mice are
consistent with the data obtained from the BMP-6 transgenic
mice (Blessing et al, 1996). Increased BMP signaling in the
epidermis of noggin knockout mice results in increased
proliferation of basal epidermal keratinocytes, downregulation
of K10 expression, and ectopic appearance of proliferating cells
and K14 expression in suprabasal epidermis (Botchkarev et al,
1999, 2002). These data were recently con¢rmed by observations
that BMP-2 administration into embryonic chicken skin induces
localized epidermal hyperproliferation (Scaal et al, 2002).
Taken together, these data suggest that the BMP e¡ect
on epidermal proliferation and di¡erentiation during skin
development is strikingly concentration dependent. Although
the expression patterns for BMP receptors suggest involvement
of BMPR-IA in mediating BMP e¡ects on cell proliferation,
whereas BMPR-IB controls cell di¡erentiation, additional
genetic and experimental data are required to prove this
hypothesis. It also remains to be determined whether BMP a¡ect
epidermal development directly or via regulation of other
signaling pathways implicated in the control of keratinocyte
proliferation and di¡erentiation (reviewed in Eckert et al, 1997;
Tomic-Canic et al, 1998; Freedberg et al, 2001).
BMP and development of cutaneous appendages Numerous
data suggest that BMP signaling is critically important for the
initiation and proper development of ectodermal derivatives,
such as tooth, feather, and hair follicle (reviewed in (Chuong,
1998; Chuong and Noveen, 1999; Chuong et al, 2000; Jernvall
and Thesle¡, 2000; Fuchs et al, 2001; Millar, 2002). In chicken
epidermis, local expression of BMP-2 precedes the induction of
feather placodes (Noramly and Morgan, 1998). Subsequently,
BMP-2 and follistatin expressions are seen in feather placode,
whereas BMP-4 expression is restricted to feather mesenchyme
(Chuong et al, 1996; Noramly and Morgan, 1998). Interestingly,
during feather bud development, only BMP antagonist gremlin
is expressed in the interplacode areas, whereas noggin and
chordin are not expressed (Ohayama et al, 2001).
During hair follicle induction in mice, both BMP-2 and
BMPR-IA are expressed in hair placode, whereas BMP-4 and
noggin expression is seen in cells of mesenchymal condensation
beneath the placode (Lyons et al, 1989, 1990; St-Jacques et al, 1998;
Botchkarev et al, 1999). Similar expression patterns (epithelial for
BMP-2 and mesenchymal for BMP-4) are found during
mammary gland initiation in mice (Phippard et al, 1996). As was
shown in di¡erent models, increased BMP signaling inhibits the
initiation phase during tooth and feather development (Neubuser
et al, 1997; Jung et al, 1998; Noramly and Morgan, 1998). In
contrast, downregulation of BMP activity by BMP antagonist
noggin stimulates feather placode induction (Noramly and
Morgan, 1998).
We showed that neutralization of BMP-2 and BMP-4
inhibitory activity by noggin stimulates the initiation phase in
hair follicle development (Botchkarev et al, 1999, 2002).
Interestingly, constitutive deletion of noggin selectively a¡ects the
inductive process in the secondary (nontylotrich) hair follicles
that represent about 90% of hair follicles in mice, whereas
primary (tylotrich) hair follicles show increased apoptosis
(Botchkarev et al, 1999, 2002).
Expression studies suggest that BMP inhibitory activity on
hair follicle induction occurs most likely by downregulation of
Lef-1 transcription factor and neural cell adhesion molecule in
hair placodes (Botchkarev et al, 1999). Lef-1 is an essential
component of Wnt/b-catenin signaling pathway and it plays
critical roles in hair follicle development (reviewed in Fuchs et
al, 2001; Millar, 2002). Lef-1 knockout mice are characterized by
reduced number of hair follicles and retardation of hair follicle
development (Genderen van et al, 1994). Conditional disruption
of b-catenin in the epidermis, or K14-driven overexpression of
the secretedWnt antagonist Dickkopf-1 lead to induction failure
of both primary and secondary hair follicles (Huelsken et al, 2001;
Andl et al, 2002). In contrast, Lef-1 overexpression leads to ectopic
hair follicle formation in the oral epithelium, and overexpression
of b-catenin, the upstream e¡ector of Lef-1 in theWnt signaling
pathway, induces hair follicle neogenesis in postnatal skin (Zhou
et al, 1995; Gat et al, 1998).
Failure of induction of secondary hair follicles observed in
grafts of noggin null skin transplanted on to SCID mice is
accompanied by strong downregulation of b-catenin expression
in the epidermis (Botchkarev et al, 2002). These data suggest a
cross-talk between BMP and Wnt/b-catenin/Lef-1 signaling
pathways in the control of the initiation phase of hair follicle
development, and are consistent with results obtained in other
models showing that BMP and Wnt signaling play antagonistic
roles during development (Baker et al, 1999). Interestingly, BMP
via downregulation of Lef-1may also inhibit neural cell adhesion
molecule expression and cell adhesion in hair placode, as it was
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recently shown that Lef-1 could regulate neural cell adhesion
molecule promoter activity (Boras and Hamel, 2002).
Increased evidence suggests that BMP signaling is also
involved in the control of cell di¡erentiation during hair follicle
development. In developing hair follicle, the inductive
interactions between keratinocytes of the hair placode and
¢broblasts of the dermal papilla lead to the construction of the
hair bulb, in which keratinocyte proliferate and di¡erentiate into
six distinct cell populations, forming the medulla, cortex, and
cuticle of the hair shaft, as well as the cuticle and Huxley and
Henle layers of the inner root sheath (Sengel, 1976; Hardy, 1992;
Philpott and Paus, 1998). BMP-2, BMP-4, and BMPR-IA are
broadly expressed in the epithelial and mesenchymal cells of the
developing hair bulb, whereas the expression of noggin is
restricted to the dermal papilla and follicular connective tissue
sheath cells (Botchkarev et al, 1999; Kulessa et al, 2000).
The role for BMP signaling in cell di¡erentiation in the hair
follicle has been addressed in two models. First, it was
determined that in noggin-null skin grafts transplanted on to
SCID mice, long-term excess of BMP leads to developmental
arrest of primary hair follicles prior to the onset of hair shaft
formation (Botchkarev et al, 2002). Second, transgenic mice
overexpressing noggin in hair matrix keratinocytes (promoter:
Msx-2 transcription factor) showed lack of external hairs due to
the alterations in the proliferation/di¡erentiation transition of
matrix keratinocytes and hair shaft synthesis (Kulessa et al, 2000).
Alterations in hair shaft formation seen in Msx-2/noggin
transgenic mice are associated with upregulation and ectopic
expression of Lef-1 in the hair follicle and with downregulation
of Foxn1 and Hoxc13 transcription factors (Kulessa et al, 2000).
Given that Lef-1, Foxn1, and Hoxc13 transcription factors bind
selected hair keratin gene promoters (Zhou et al, 1995; Prowse
et al, 1999), these data prove that BMP signaling is causally
involved in the control of hair shaft-speci¢c di¡erentiation in
the hair follicle. Furthermore, these data suggest that the genetic
program of hair shaft formation is tightly controlled by the local
balance of noggin and BMP and that either excess or limitation
of BMP signaling may a¡ect initiation and maintenance of the
hair shaft-speci¢c di¡erentiation in the hair bulb keratinocytes.
BMP and Biology of Postnatal Skin Numerous data suggest
that biologic mechanisms regulating cell proliferation,
di¡erentiation, and apoptosis in skin during development are
ultimately involved in the maintenance of skin homeostasis in
postnatal life (reviewed in Fuchs and Raghavan, 2002). BMP
ful¢ll diverse functions in postnatal maintenance of
musculoskeletal, reproductive, cardiovascular, respiratory, and
nervous systems (reviewed in Myazono et al, 2001). Below we
review data suggesting that BMP signaling plays important parts
in regulating multiple functions (epidermal proliferation and
di¡erentiation, hair follicle cycling, melanogenesis, and
innervation) in normal postnatal skin (Fig 3).
BMP and epidermal keratinocytes Biochemical studies
suggest that BMP-2 transcripts are expressed in proliferating and
di¡erentiating murine keratinocytes in vitro (Park and Morasso,
2002). Primary mouse keratinocytes induced to di¡erentiate in
methylcellulose suspension culture express BMP-6 mRNA and
protein (Drosdo¡ et al, 1994). 12-O-tetradecanoyl-phorbol-13-
acetate-induced di¡erentiation of primary mouse keratinocytes
is also accompanied by increased BMP-6 expression (Wach et al,
2001). In adult human epidermis, expression of BMPR-IA,
BMPR-IB, and BMPR-II is seen in suprabasal keratinocytes,
whereas no BMP receptors are detected in basal epidermal cells
(Hwang et al, 2001).
In vitro data suggest that, similar to the embryonic skin, BMP
signaling is involved in the control of keratinocyte proliferation
and di¡erentiation in postnatal skin. In primary mouse
keratinocytes BMP-6 inhibits cell growth and DNA synthesis
(Drosdo¡ et al, 1994; D’Souza et al, 2001). Both BMP-2 and
BMP-6 induce di¡erentiation of primary mouse keratinocytes
in culture (Drosdo¡ et al, 1994; D’Souza et al, 2001; McDonnell
et al, 2001; Park and Morasso, 2002). In di¡erentiating epidermal
keratinocytes, BMP-6 stimulates K1 expression through the Smad
pathway, whereas BMP-2 activates the expression of Dlx-3
transcription factor via recruitment of the Smad1/Smad4
complex (McDonnell et al, 2001; Park and Morasso, 2002).
BMP-6 also stimulates involucrin expression in cultured murine
keratinocytes (D’Souza et al, 2001).
It appears that the BMP e¡ects on epidermal proliferation/
di¡erentiation are distinct from those of TGF-b proteins, which
inhibit both proliferation and di¡erentiation of the epidermal
keratinocytes (Dahler et al, 2001; reviewed in Freedberg et al,
2001). BMP action on epidermal keratinocytes, however, is quite
similar to the activin e¡ects, as activin also inhibits keratinocyte
proliferation and stimulates their di¡erentiation (Seishima et al,
1999). Although the transcriptional targets for BMP signaling in
epidermal keratinocytes remain to be elucidated, taken together
these data suggest BMP signaling as an important component of
the molecular network regulating epidermal proliferation and
di¡erentiation in normal postnatal skin.
BMP and postnatal hair follicle growth During postnatal
development, the hair follicle shows cyclic activity with periods
of relative resting (telogen), active growth and hair shaft
production (anagen), and apoptosis-driven regression (catagen)
(Paus, 1996; Paus and Cotsarelis, 1999; Cotsarelis and Millar,
2001; Stenn and Paus, 2001). The tightly controlled balance of
numerous growth stimulatory and inhibitory factors regulates
cyclic activity of the hair follicle. Hair follicle morphogenesis
and initiation of a new growth phase in resting postnatal hair
follicles have many similar aspects and both are characterized by
activation of di¡erentiation programs that lead to the
construction of a ¢ber producing hair bulb. Increased evidence
suggests that both processes are regulated by similar mechanisms
and require the activity of Wnt/b-catenin, Shh, and BMP
signaling pathways (reviewed in Fuchs et al, 2001).
During induced hair cycle in C57BL/6 mice, BMP4, BMPR-
IA, and noggin show spatiotemporal changes in their expression
patterns and are involved in the control of hair follicle telogen^
anagen transition (Botchkarev et al, 2001). During telogen, BMP4
is produced by both dermal papilla ¢broblasts and secondary
germ keratinocytes, and most likely interacts with BMPR-IA,
which is selectively expressed in the secondary germ, thus
preventing the onset of anagen development. Activation of hair
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Figure 3. Schematic representation of the BMP e¡ects in postnatal
skin. BMP signaling plays important parts in regulating multiple func-
tions in normal postnatal skin. BMP stimulate di¡erentiation of epidermal
and hair follicle keratinocytes, inhibit initiation of hair growth, promote
melanocyte proliferation and modulate melanogenesis, as well as an in-
crease in calcitonin gene-related peptide expression in sensory neurons
innervating skin.
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growth phase in postnatal telogen hair follicle is associated with
upregulation of noggin in follicular epithelium and mesenchyme.
Administration of noggin induces active hair growth phase in
postnatal telogen mouse skin both in vivo and in situ (Botchkarev
et al, 2001). As noggin binds BMP4 with a⁄nity 10^15 times
higher than BMPR-IA (Zimmerman et al, 1996), noggin most
likely prevents BMP4 interaction with BMPR-IA expressed in
the secondary germ of telogen hair follicle and thus stimulates
anagen initiation.
In contrast to noggin, BMP4 plays important inhibitory roles
during hair follicle telogen^anagen transition (Botchkarev et al,
2001). BMP4 and BMPR-IA are markedly downregulated in the
germinative compartment of early anagen hair follicle, which is
characterized by increased keratinocyte proliferation (Wilson et al,
1994). BMP4 administration blocks both depilation-induced
anagen development and keratinocyte proliferation in the
secondary hair germ of the nontylotrich (secondary) hair
follicles. These results are fully consistent with data showing that
in embryonic skin BMP excess suppresses induction of secondary
hair follicles (Botchkarev et al, 2002).
Interestingly, the anagen-inducing e¡ect of noggin is mediated
at least in part by the activation of Shh signaling in the hair
follicle. Shh is essential for hair follicle morphogenesis and
hair cycle initiation (reviewed in Dlugosz, 1999). Constitutive
deletion of Shh results in the arrest of hair follicle
morphogenesis at the bud stage (St-Jacques et al, 1998; Chiang
et al, 1999). Increased dermal expression of Shh or Shh blockade
by neutralizing antibodies alter hair follicle transition from
telogen to anagen in postnatal skin (Sato et al, 1999; Wang et al,
2000a). Shh is upregulated in the hair follicle after noggin
treatment, whereas BMP4 downregulates Shh (Botchkarev
et al, 2001). Furthermore, anagen-inducing activity of noggin
is abrogated by anti-Shh antibody in situ (Botchkarev
et al, unpublished observations). This suggests that noggin-
neutralizing BMP4 activity represents an important upstream
e¡ector of Shh during initiation of the hair growth phase in
telogen hair follicle. These data are consistent with previous
observations that BMP4 may antagonize Shh signaling during
tooth and limb development (Zuniga et al, 2000).
In actively growing postnatal hair follicles, BMP-4, BMPR-
IA, and noggin are expressed in the dermal papilla, hair matrix,
as well as in proximal outer and inner root sheaths (Botchkarev
et al, 2001). BMP signaling is important for hair shaft speci¢c
di¡erentiation (Kulessa et al, 2000). Important downstream
component of BMP signaling is Msx-2 transcription factor,
which is expressed in hair matrix keratinocytes and mediates
BMP e¡ects on the expression of Lef-1, Foxn1, and Hoxc13
transcription factors, which in turn regulate expression of hair
keratin genes (reviewed in Fuchs et al, 2001).
Interestingly, Msx-2 transcription factor is also involved in
mediating BMP4-induced apoptosis in a variety of embryonic
tissues (Marazzi et al, 1997; Chen and Zhao, 1998). Msx-2
overexpressing mice show decreased volume of proximal hair
bulb and shrunken hair matrix region with reduced number of
hair keratinocyte precursors (Jiang et al, 1999). Thus, by
regulating Msx-2 expression BMP may control the size and cell
number in actively growing hair follicles, as well as regulate
apoptosis-driven hair follicle regression. Indeed, in growing
teeth, neutralization of BMP-4 by ectopically applied noggin
leads to inhibition of apoptosis, increased tooth size, and the
formation of molars instead of incisors (Tucker et al, 1998). In
developing hair follicles, increased BMP signaling due to the
deletion of the BMP antagonist noggin also leads to the
upregulation of apoptosis (Botchkarev et al, 1999). It remains to
be determined, however, whether BMP signaling controls the
size of postnatal hair follicles by inducing apoptosis.
BMP and functions of neural crest derivatives in postnatal
skin BMP and BMP antagonist noggin are intimately
involved in the control of development and migration of neural
crest cells during embryogenesis (reviewed in Christiansen et al,
2000). In primary quail neural crest cultures, BMP-2 treatment
increases melanin synthesis via stimulation of tyrosinase gene
expression in melanocyte precursors (Bilodeau et al, 2001). In
melanocytes isolated from human newborn skin, however,
BMP-4 stimulates proliferation, decreases melanin content, and
downregulates tyrosinase message and protein.1 This suggests
that the e¡ects of BMP on melanocytes strongly depend on the
latter di¡erentiation stage, expression of BMP receptors, and on
other growth factor signaling pathways that may modulate BMP
action on melanocytes.
It was also shown that BMP signaling controls cell fate
in embryonic neural crest cells and stimulates neural crest
progenitor di¡erentiation into autonomic neurons (Christiansen
et al, 2000). This suggests that BMP also a¡ects the development
and maintenance of postnatal skin innervation. In developing
sympathetic neurons, BMP-2 regulates expression of TrkC, the
high-a⁄nity receptor for neurotrophin-3 (Kobayashi et al, 1998).
Still, it is yet unknown whether BMP signaling is involved in
regulating sympathetic neurons that innervate skin targets. It
was shown, however, that BMP stimulate survival and
responsiveness of sensory neurons to neurotrophic factors by
increasing the expression of the high-a⁄nity neurotrophin
receptors TrkB and TrkC (Farkas et al, 1999).
Furthermore, it has been shown that neurons in sensory dorsal
root ganglia express BMP receptors, and the expression of a
sensory neuropeptide calcitonin gene-related peptide in dorsal
root ganglion neurons is stimulated by BMP-2, BMP-4, and
BMP-6 (Ai et al, 1999). Calcitonin gene-related peptide is an
important mediator of the skin neuroimmune network and it
controls a variety of functions in skin cells, including inhibition
of antigen presentation by Langerhans cells, release of histamine
from mast cells and vasodilatation (reviewed in Torii et al, 1997;
Levite, 2000). Thus, by regulating calcitonin gene-related
peptide expression, BMP may in£uence cell^cell interactions in
skin immune and circulatory systems.
BMP Involvement in Pathologic Processes in Skin Several
lines of evidence suggest involvement of factors that control
cutaneous development (Shh, Wnt family, TGF-b family, stem
cell factor, epidermal growth factor) in a variety of pathologic
processes in adult skin, including tissue regeneration, tumor
growth, allergic reactions, etc. (reviewed in Loomis, 2001). We
summarize here the data showing that BMP are involved in the
control of wound healing, psoriasis, and carcinogenesis in adult
skin.
BMP and wound healing After skin injury in mice, BMP-6
transcripts and protein are strongly upregulated in the
keratinocytes of the newly formed epidermis and in dermal
¢broblasts of the wound bed (Kaiser et al, 1998). High levels of
BMP-6 mRNA and protein are also detected in chronic
wounds of human skin (Kaiser et al, 1998). In BMP-6
overexpressing transgenic mice (promoter: K10), re-epi-
thelization of skin wounds is signi¢cantly delayed and scar
formation is enhanced (Kaiser et al, 1998). BMP-2 application to
the wound bed of fetal lambs induces scar formation associated
with a marked increase of epidermal keratinization and
epidermal and dermal thickness (Stelnicki et al, 1998). Epidermal
wounds treated with BMP-2 and TGF-b healed with a similar
scarring process indicating that both growth factors are
important for collagen-producing activity by ¢broblasts during
the wound healing process (Stelnicki et al, 1998). This suggests
that BMP signaling regulates the wound-healing process by
changing the proliferative activity and/or di¡erentiation of
epidermal keratinocytes and by altering the collagen-producing
activity of dermal ¢broblasts. It is unknown whether BMP
directly stimulate collagen synthesis in dermal ¢broblasts during
wound healing, as they do so in osteoblasts (reviewed in
Yamaguchi et al, 2000), and it remains to be determined whether
elevated BMP levels modulate activity of other growth factors,
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such as activin and TGF-b (reviewed in Munz et al, 2001;
Verrecchia and Mauviel, 2002).
BMP and psoriasis Several lines of evidence suggest that BMP
plays a part in the pathophysiology of psoriasis. Transgenic mice
overexpressing BMP-6 in suprabasal epidermal keratinocytes
under the control of K10 promoter develop skin lesions cha-
racteristic of psoriasis: parahyperkeratosis and hyperpro-
liferation of the epidermis, alterations of keratin and integrin
expression, extensive dermal capillarization, and dermal cell
in¢ltrates (Blessing et al, 1996). Long-term treatment of C57BL/6
mice with BMP-2 or BMP-4 also result in thickening of the
epidermis with development of psoriasis-like lesions
(Botchkarev et al, unpublished observations). Elevated BMP
signaling may stimulate angiogenesis via upregulation of
vascular endothelial growth factor synthesis, as is shown in
osteoblasts (Deckers, 2001; Kozawa and Uematsu, 2001).
Although the BMP role in psoriasis development remains to be
determined, the above data suggest that BMP antagonists could
help in psoriasis management.
BMP and skin carcinogenesis Several lines of evidence
suggest that BMP signaling may contribute to skin
carcinogenesis. Transgenic studies suggest that overexpression of
BMP-4 or BMP-6 in murine epidermis is accompanied by
increased resistance to 12-O-tetradecanoyl-phorbol-13-acetate-
induced tumorigenesis (Blessing et al, 1995; Wach et al, 2001).
Furthermore, in chemically induced murine epidermal tumors,
Smad1 and Smad5 proteins are strongly downregulated, whereas
Smad7 is upregulated (He et al, 2001). Importantly, tumor
resistance in transgenic mice overexpressing BMP-6 in the
suprabasal layer of the epidermis (promoter: K10) is associated
with a signi¢cant increase in apoptotic cells and downregulation
of the transcriptional regulator AP-1, which is seen after 12-O-
tetradecanoyl-phorbol-13-acetate treatment (Wach et al, 2001).
This suggests that BMP signaling plays a suppressive role in
epithelial tumor formation in murine skin.
Immunohistochemical data show that in human basal cell
carcinoma R-Smad expression is decreased (Lange et al, 1999).
BMP-2 expression is found in the cytoplasm of shadow cells in
human pilomatrichoma, and BMP-2 may contribute to the
di¡erentiation of tumor cells into the bone cells frequently seen
in this type of benign skin tumors (Kurokawa et al, 2000). The
role of BMP signaling in the formation of tumors in human
skin remains to be determined. BMP, however, may also
suppress tumor formation by antagonizing Shh activity in
epithelial cells. Shh, an essential epithelial signal that promotes
hair follicle morphogenesis in embryonic skin (St-Jacques et al,
1998; Chiang et al, 1999), plays important stimulatory roles in the
formation of basal cell carcinoma in both humans and mice
(reviewed in Oro, 2001). Overexpression of Shh or its
downstream e¡ector Gli2 in basal epidermal keratinocytes
(promoter: K14) induces the development of basal cell carcinoma
(Oro et al, 1997; Grachtchouk et al, 2000). As was shown in
developing teeth and in postnatal hair follicles, however,
increased BMP activity both in vitro and in vivo may
downregulate Shh mRNA (Zuniga et al, 2000; Botchkarev et al,
2001). Thus, the anti-neoplastic activity of BMP in epidermal
carcinogenesis appears to be mediated by downregulating AP-1
and Shh pathways.
CONCLUSIONS
During the last decade, tremendous progress has been achieved in
delineating the molecular structure and functions of BMP, BMP
receptors, and BMP antagonists. While initially identi¢ed as
growth factors stimulating bone regeneration, BMP are now re-
cognized as powerful regulators of tissue development, homeos-
tasis, and remodeling. BMP activity in developing and adult
tissues is modulated and antagonized on di¡erent levels (extracel-
lular, cytoplasmic, and nuclear). In normal skin, BMP function as
important factors controlling epidermal proliferation and di¡er-
entiation, hair follicle growth, melanogenesis, and innervation.
BMP are also implicated in the regulation of wound healing and
hyperproliferative skin disorders, such as psoriasis and in cancer
development. BMP e¡ects on the hair follicle suggest that BMP
antagonists and agonists may represent a new tool for therapeutic
corrections of hair growth disorders. Additional research is re-
quired, however, to bridge the gap between our current knowl-
edge of BMP functions in the skin and their potential clinical
applications.The progress in this area of research would hopefully
lead to the development of multiple applications for using BMP
and BMP antagonists in skin and hair growth disorders.
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